Cheryl L. Cohen's Insider Trades & SAST Disclosures
Cheryl L. Cohen's most recent trade in Celldex Therapeutics Inc. was a trade of 16,500 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Cheryl L. Cohen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celldex Therapeutics Inc. | Cheryl L. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,500 | 16,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| ImmunityBio Inc | Cheryl L. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 77,633 | 77,633 | - | - | Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Cheryl L. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 11,300 | 11,300 | - | - | Non-Qualified Stock Option (right to buy) | |
| ImmunityBio Inc | Cheryl L. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 158,263 | 158,263 | - | - | Stock Option (right to buy) | |
| MEI Pharma Inc | Cheryl L. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Celldex Therapeutics Inc. | Cheryl L. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 27,200 | 27,200 | - | - | Non-Qualified Stock Option (right to buy) | |
| ImmunityBio Inc | Cheryl L. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 167,937 | 167,937 | - | - | Stock Option (right to buy) | |
| ImmunityBio Inc | Cheryl L. Cohen | Director | Sale of securities on an exchange or to another person at price $ 10.12 per share. | 20 Aug 2021 | 14,801 | 200,617 | - | 10.1 | 149,795 | Common Stock |
| ImmunityBio Inc | Cheryl L. Cohen | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 20 Aug 2021 | 9,976 | 215,418 | - | 10.0 | 99,808 | Common Stock |
| ImmunityBio Inc | Cheryl L. Cohen | Director | Sale of securities on an exchange or to another person at price $ 10.12 per share. | 17 Aug 2021 | 43,398 | 227,527 | - | 10.1 | 439,361 | Common Stock |
| ImmunityBio Inc | Cheryl L. Cohen | Director | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 17 Aug 2021 | 2,133 | 225,394 | - | 10.0 | 21,389 | Common Stock |
| MEI Pharma Inc | Cheryl L. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| ImmunityBio Inc | Cheryl L. Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 26,064 | 26,064 | - | - | Stock Option (right to buy) | |
| MEI Pharma Inc | Cheryl L. Cohen | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges